What changed
Moment
Not every moisturizer does the same job.
Not every moisturizer does the same job.
Barrier repair is not the same as any cream. Atopic dermatitis reviews explain why some layers fail to hold water. Not a menopause cream trial.
The mechanism, in plain language
Barrier repair is not the same as any cream. Reviews of atopic dermatitis care argue that some everyday moisturizers hydrate poorly as barrier therapy, and that humectant-heavy layers without the right lipid and occlusion logic can fail to hold water. That failure mode is one way a layer can feel like it sits on the surface, or like it is gone by bed. That is barrier math language, not a menopause cream trial.
These papers studied atopic dermatitis and barrier formulations, not a peri/post-menopause cream RCT. Use them to question the mental model that “moisturizer” is one thing. Not to diagnose your skin. Not to sell a jar.
Honesty limits
This page explains reviews and one physiology paper. It does not tell you what your skin is doing.
- AD frame first. Elias 2019 and Elias 2022 are written for atopic dermatitis barrier care.
- “Not all moisturizers help” is their review argument, not a menopause prevalence number.
- Physiologic barrier repair language means the three key stratum corneum lipids in enough amount and a sensible ratio, not a shopping list on this site.
- Nobody here measured “sits useless” or “gone by bed” as a study endpoint. That is moment language for a felt film failure.
- Elias COI. Peter Elias is a co-inventor of a prescription barrier-repair product (EpiCeram / Primus). Cite principles, not brands. There is no brand call to action on this page.
- Ueda support only. Dose and timing on one moisturizer system. The work had TOKIWA funding and employee co-authors. Disclose that.
- No cream is sold on MenoDerm. No SisLuna product talk.
- Optional cross-link only. Kendall’s menopause lipid work was buttock skin and did not test cream. It is not co-proof for this moment.
Experimental mortar note (non-menopause-specific)
After solvent lipid strip, the ceramide fraction of SC lipids raised water-holding conductance most in this forearm model.
In experimental forearm models, surfactant damage and solvent lipid strip impair the stratum corneum’s water-holding capacity. Restoring intercellular stratum corneum lipids recovers that capacity better than sebaceous-rich lipids; in the 1986 work, the ceramide fraction raised conductance most among the separated fractions tested. These are non-menopause-specific barrier mechanism papers, not peri-menopause trials and not a product pitch.
This note sits beside Elias and Ueda. It does not replace those cards. It deepens general mortar and water-holding mechanism only.
- Imokawa et al. 1989. Arch Dermatol Res. Six healthy male forearms. 5% SDS. Intercellular lipids depleted; water retention down. SCLs at 10% in W/O cream, two daily applications: conductance up versus base; sebaceous-rich lipids: no significant recovery. Kao lab affiliation. Abstract truncated on later fraction detail.
- Imokawa et al. 1986. J Invest Dermatol. Acetone/ether forearm depletion lasting more than 4 days. SCL recovers conductance; sebaceous-rich lipids do not. Ceramide fraction: highest conductance recovery among fractions tested. Glycolipids and cholesterol also recovered versus no application; free fatty acid and cholesterol ester did not. Volunteer n is not stated in the abstract.
- Non-menopause-specific. Not peri-menopause. Not face. Not Shop. Not “buy ceramides cream.”
- No cream sold on MenoDerm. No SisLuna product talk.
- Do not invent a menopause link, an n for 1986, or post-truncation 1989 fraction results.
Elias PM et al. Skin Pharmacol Physiol. 2019;32:1-7. doi:10.1159/000493641
Sources
- Elias PM, Wakefield JS, Man M-Q. Skin Pharmacol Physiol. 2019;32:1-7. doi:10.1159/000493641
- Elias PM. Ann Allergy Asthma Immunol. 2022;128:505-511. doi:10.1016/j.anai.2022.01.012
- Ueda Y, Murakami Y, Saya Y, Matsunaka H. J Cosmet Dermatol. 2022;21:3095-3101. doi:10.1111/jocd.14560
- Imokawa G, Akasaki S, Minematsu Y, Kawai M. Arch Dermatol Res. 1989;281:45-51. doi:10.1007/bf00424272
- Imokawa G, Akasaki S, Hattori M, Yoshizuka N. J Invest Dermatol. 1986;87:758-761. doi:10.1111/1523-1747.ep12456950